Fresh hope for pancreatic cancer patients as new vaccine shows promise in early trial
Monday, 11 August 2025 () A new pancreatic cancer vaccine has appeared to slow disease progression and increase survival for patients in an early trial.
People with head and neck cancer in England will be fast-tracked on to a clinical trial for a “potentially transformative” vaccine under new NHS plans. Report by Gluszczykm. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
Patients in England with aggressive head and neck cancers will be fast-tracked into a new cancer vaccine trial. Professor Peter Johnson, the National Clinical Director for Cancer for NHS England says..
It is a pivotal moment as the CDC’s Advisory Committee on Immunization Practices (ACIP) convenes for its first meeting since the sweeping overhaul of its voting members. Among the new appointees is..